Clinton targets drug firm ‘price-gouging’

Hillary Clinton may have found the perfect target to show that she’ll be as tough on corporations as her Democratic presidential rival, Bernie Sanders: Big Pharma.

Following up on her tweet last week against “price-gouging” by Turing Pharmaceuticals that sent biotech stocks plummeting, the Democratic front-runner released a hard-hitting television ad on Monday suggesting that CEO Martin Shkreli decided to lower prices after she went after him.

In between, she unveiled a proposal to cap out-of-pocket drug expenses, offering tax credits to help families deal with soaring costs, forcing drug manufacturers to invest more on research and development, and obliging companies to invest in the production of generics.